Endocrinology
Osteoporosis is a progressive bone disease causing decreased bone density and increased fracture risk. IV bisphosphonate infusion therapy can prevent further bone loss and reduce fractures.
Osteoporosis is a progressive bone disease characterized by decreased bone density and strength, making bones more fragile and susceptible to fractures. It develops silently over many years, often without symptoms until a fracture occurs. It is most common in postmenopausal women due to hormonal changes, but also affects men and younger individuals. While osteoporosis cannot be fully reversed, infusion-based treatments can help prevent further bone loss and significantly reduce fracture risk.
Consult a doctor for unexplained fractures after minimal trauma, persistent severe back pain, or a noticeable decrease in height. Seek immediate care for severe back pain after a fall or difficulty walking from a possible hip fracture.
Bisphosphonate infusions and other IV bone therapies offer an effective alternative for patients who cannot tolerate daily oral medications. Infusion therapy allows for annual or quarterly dosing with clinical monitoring, improving adherence and reducing the gastrointestinal side effects associated with oral regimens.
Prolia, Reclast